Zika is caused by a virus that is transmitted by mosquitoes. Nonhuman primates are the reservoir in the wild. The virus has also been found in livestock, horses, sheep, water buffalo, zebra, lions, ducks, rodents, and bats; however, those animals have not been shown to spread the disease that the virus causes. Animals cannot transmit Zika virus directly to humans, but they can transmit it to a mosquito when bitten.
Etiology and Pathogenesis of Zika
Zika is caused by the virus Orthoflavivirus zikaense (OZ), formerly known as Zika virus, in the family Flaviviridae. OZ is a small, enveloped virus with a positive-sense RNA genome. The Flaviviridae family includes other mosquito-borne viruses, such as those that cause dengue, yellow fever, and West Nile virus infection.
Infected Aedes mosquitoes, especially Aedes aegypti, transmit OZ to humans primarily through bites (A aegypti feeds almost exclusively on humans) (1, 2, 3). See .
Diagram showing how Zika virus is transmitted from mosquitoes to humans, from humans to mosquitoes, and between humans.
Developed by the CDC. This diagram is available for no charge at https://www.cdc.gov/zika/causes. (Reference to specific commercial products, manufacturers, companies, or trademarks does not constitute their endorsement or recommendation by the US Government, Department of Health and Human Services, or Centers for Disease Control and Prevention.)
OZ persists in a sylvatic cycle in which forest Aedes mosquitoes acquire the virus by feeding on infected nonhuman primates. These infected mosquitoes can subsequently transmit the virus to both nonhuman primates and humans. Mosquito species implicated in OZ transmission in sylvatic cycles include Aedes africanus, Aedes albopictus, Aedes apicoargenteus, and Aedes furcifer (1, 3).
OZ was first isolated from a rhesus monkey (Macaca mulatta) in Uganda in 1947 and later detected in native nonhuman primates and forest-dwelling Aedes mosquitoes in Africa. The virus remained confined to the equatorial regions of Africa and Asia, cycling among nonhuman primates, arboreal mosquitoes, and occasionally humans.
OZ strains in Asia have a different lineage from those in Africa.
OZ did not pose a substantial threat to human health until it emerged in Latin America, where it was likely introduced into Brazil in 2013. Introduction of the virus in Latin America led to an epidemic in the Americas, where it caused severe congenital malformations in infants and infected approximately 8.5 million people in 2015 and 2016 (1, 2, 3, 4).
Nonhuman primates are widely thought to act as reservoirs of OZ in Africa and Asia. However, their role in Latin America is still uncertain. In addition, debate continues, and no clear consensus exists, on whether pets and peridomestic animals can serve as reservoirs for OZ. The risk of direct zoonotic transmission is low (1, 2, 3, 4, 5).
Researchers have developed animal models in mice and rhesus macaques to study OZ (3, 6).
Clinical Findings of Zika
Diagnosis of Zika
Nucleic acid testing
A nucleic acid amplification test (NAAT) is the preferred method for diagnosis of Zika. However, a negative result does not necessarily rule out infection by OZ, because Zika virus RNA is in serum at low levels and only for a short period of time, so the window for detecting it via a NAAT might have been missed (8). RT-PCR testing can also be used. Cross-reactivity among flaviviruses is a known problem (2, 3, 6, 7, 8).
Control of Zika
Release of sterile or Wolbachia-infected mosquitoes
Prevention of mosquito bites via physical and chemical barriers
Mosquito Control to Prevent Zika
Controlling Aedes mosquitoes is difficult. Chemical larvicides and adulticides, along with source reduction techniques, have limitations (9). Biological control methods lack robust evidence of sustained effectiveness.
Two methods show promise for decreasing infected mosquito populations over time (10):
releasing sterile or genetically altered males to mate with wild females
releasing Wolbachia-infected females, in which the bacteria block susceptibility to OZ in infected mosquitoes and their offspring
Avoiding Occupational Exposure to Prevent Zika
Various methods can be used to prevent bites by mosquitoes that could transmit OZ to individuals doing fieldwork (11, 12):
applying EPA-registered insect repellents
treating clothing and gear with permethrin insecticide
wearing long, loose-fitting shirts and pants
controlling mosquitoes indoors and outdoors by using window screens and air-conditioning
protecting sleeping individuals with a mosquito net in areas with inadequate screens or air-conditioning
Travel alerts for Zika should be followed and adhered to. Pregnant women should avoid travel to areas with ongoing Zika outbreaks. Women who are trying to conceive and have had possible Zika exposure should delay conception for 3 months after the onset of symptoms or the last possible OZ exposure. A physician can discuss potential risks, health effects, and methods of protection.
Currently, no vaccine against Zika is available.
Laboratory Precautions to Prevent Zika
For laboratory workers who handle Zika-transmitting pathogens, the primary hazard is contact with infected specimens, work with arthropod vectors, and contact with infected materials through skin punctures, cuts, or abrasions. A variety of precautions can be taken to prevent infection (5, 13):
All in vitro and in vivo activities, including animal studies, must be conducted at a Biosafety Level 2 (BSL-2) facility.
Work with indigenous arthropod vectors must be performed at a BSL-3 facility.
Arthropod containment guidelines must be followed in vector studies.
Pregnant women, women trying to become pregnant, and sexual partners of these women should take extra precautions to protect against possible exposures when working in a laboratory where OZ is propagated or handled, or they should avoid working in such laboratory settings. Consideration should be given to reassigning the worker to tasks that decrease or eliminate the risk of OZ exposure.
Applicable occupational safety standards—the Occupational Safety and Health Administration (OSHA)’s Bloodborne Pathogens and Needlestick Prevention and Personal Protective Equipment standards, including the Respiratory Protection standard, and other applicable OSHA and state plan requirements for protecting workers from laboratory hazards—must be followed.
Key Points
Zika is caused by Orthoflavivirus zikaense (OZ) and is transmitted primarily by Aedes mosquitoes.
Although nonhuman primates are reservoirs for OZ in Africa and Asia, reservoir species for North and South America are unknown.
Clinical signs of OZ infection in nonhuman primates can range from mild fever to severe fetal brain defects.
Pregnant women, women who are trying to conceive, and their sexual partners should follow guidelines for traveling to areas with ongoing Zika outbreaks and for working in laboratories where exposure to OZ is possible.
Prevention of OZ infection depends on controlling Aedes mosquitoes and avoiding mosquito bites.
For More Information
How Zika Spreads. CDC Zika Virus.
Preventing and Managing Laboratory Worker Exposure to Zika Virus. OSHA FactSheet.
Also see pet owner content regarding Zika.
References
CDC. How Zika spreads. July 15, 2026. Accessed October 10, 2026. https://www.cdc.gov/zika/causes/index.html
de Oliveira-Filho EF, Carneiro IO, Fischer C, et al. Evidence against Zika virus infection of pets and peri-domestic animals in Latin America and Africa. J Gen Virol. 2022;103(1):001709. doi:10.1099/jgv.0.001709
Bueno MG, Martinez N, Abdalla L, Duarte dos Santos CN, Chame M. 2016. Animals in the Zika virus life cycle: what to expect from megadiverse Latin American countries. PLoS Negl Trop Dis. 2016;10(12):e0005073. doi:10.1371/journal.pntd.0005073
Cohen J. Are wild monkeys becoming a reservoir for Zika virus in the Americas?Science. October 31, 2018. doi:10.1126/science.aav9136
Public Health Agency of Canada. Zika virus April 14, 2016. Biosafety Advisory. May 3, 2016. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/zika-virus-april-14-2016.html
Vue D, Tang Q. Zika virus overview: transmission, origin, pathogenesis, animal model and diagnosis. Zoonoses. 2021;1(1):10.15212/zoonoses-2021–0017. doi:10.15212/zoonoses-2021-0017
McCommon GW. Zika virus. In: Samples OM, McCommon GW, Terrill TH, Stose LL, eds. The One Health Model as Applied to Zoonotic Diseases. John Wiley & Sons; 2025:70-72. doi:10.1002/9781119985853.ch3.14
CDC. Clinical testing and diagnosis for Zika virus disease. November 19, 2025. Accessed October 10, 2026. https://www.cdc.gov/zika/hcp/diagnosis-testing/index.html
CDC. Preventing mosquito bites. August 28, 2024. Accessed October 29, 2026. https://www.cdc.gov/mosquitoes/prevention
Rahul A, Reegan AD, Shriram AN, Fouque F, Rahi M. Innovative sterile male release strategies for Aedes mosquito control: progress and challenges in integrating evidence of mosquito population suppression with epidemiological impact. Infect Dis Poverty. 2024;13:91. doi:10.1186/s40249-024-01258-5
CDC. Preventing Zika. January 30, 2025. Accessed October 10, 2026. https://www.cdc.gov/zika/prevention/index.html
EPA. Find the repellent that is right for you. Last updated September 8, 2026. Accessed October 10, 2026. https://www.epa.gov/insect-repellents/find-repellent-right-you
American Committee of Medical Entomology (ACME), American Society of Tropical Medicine & Hygiene (ASTMH). Accessed September 1, 2026. https://www.astmh.org/subgroups/acme



